Lobular
Showing 1 - 25 of 447
Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)
Not yet recruiting
- Metastatic Breast Cancer
- Lobular Breast Carcinoma
- Blood Specimen
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 19, 2023
Carcinoma, Lobular Trial ([18F]fluoroestradiol (FES))
Not yet recruiting
- Carcinoma, Lobular
- [18F]fluoroestradiol (FES)
- (no location specified)
Jul 18, 2023
Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)
Not yet recruiting
- Lobular Breast Carcinoma
- 68Ga-FAPI-46 PET scan
-
Monaco, MonacoCentre Hospitalier Princesse Grace
Jun 27, 2023
Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:
Recruiting
- Pleomorphic Lobular Breast Carcinoma in Situ
- Breast Florid Lobular Carcinoma in Situ
- Surgical wide local excision
- +4 more
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Nov 14, 2023
Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,
Recruiting
- Metastatic Cancer
- +2 more
- 18F-fluorofuranylnorprogesterone
- +2 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 10, 2023
Searching for Novel Germline Mutations in Lobular Breast Cancer
Recruiting
- Lobular Breast Carcinoma
- +3 more
- Illumina panel
-
Milan, ItalyEuropean Institute of Oncology
Sep 12, 2022
Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States
Not yet recruiting
- Anatomic Stage I Breast Cancer
- +3 more
- Endocrine Therapy
- +7 more
-
Atlanta, Georgia
- +4 more
Jun 15, 2023
Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each
Recruiting
- Atypical Hyperplasia
- Lobular Carcinoma in Situ
- Tamoxifen
- +2 more
-
Evanston, Illinois
- +1 more
Jan 20, 2023
Invasive Lobular Breast Carcinoma Trial in Salt Lake City ([18F]Fluoroestradiol (FES) PET/CT)
Recruiting
- Invasive Lobular Breast Carcinoma
- [18F]Fluoroestradiol (FES) PET/CT
-
Salt Lake City, UtahHuntsman Cancer Institute
Jun 14, 2022
Standard Breast Cancer Risk Assessment for African American and
Not yet recruiting
- Breast Atypical Ductal Hyperplasia
- +3 more
- Biospecimen Collection
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 22, 2023
Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston
Completed
- Breast Atypical Ductal Hyperplasia
- +4 more
- Bexarotene
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
CDH1 Germline Mutations in Lobular Breast Cancer
Active, not recruiting
- Lobular Breast Carcinoma
- CDH1 Gene Inactivation
-
Milan, ItalyEuropean Institute of Oncology
Jan 11, 2022
Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,
Recruiting
- Invasive Lobular Breast Carcinoma
- +2 more
- Entrectinib
- +2 more
-
Brussels, Belgium
- +9 more
May 4, 2022
Breast Diseases, Mastitis Granulomatous, Psychiatric Disorder Trial in Wuhan (conservative treatment)
Enrolling by invitation
- Breast Diseases
- +2 more
- conservative treatment
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
May 24, 2022
BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)
Not yet recruiting
- BRCA Mutation
- +3 more
- Tamoxifen 10 Mg Tablet
- +2 more
-
Genoa, Italy
- +3 more
Sep 11, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma, Metastatic Breast Lobular Carcinoma Trial in Atlanta
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Computed Tomography
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 9, 2022
Refractory Granulomatous Lobular Mastitis Trial in Wuhan (Intralesional triamcinolone injection, No intralesional triamcinolone
Recruiting
- Refractory Granulomatous Lobular Mastitis
- Intralesional triamcinolone injection
- No intralesional triamcinolone injection
-
Wuhan, Hubei, ChinaQianqian Yuan
Mar 15, 2022
Molecular Analysis of the Sloane Project
Enrolling by invitation
- DCIS
- +3 more
-
London, United KingdomKing's College London
May 11, 2023
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation
Active, not recruiting
- Breast Cancer
- +4 more
- External Beam Radiation Therapy
- +2 more
-
Richmond, Virginia
- +1 more
Dec 16, 2022
Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer Trial in United Kingdom (Crizotinib Oral Capsule
Recruiting
- Lobular Breast Carcinoma
- +3 more
- Crizotinib Oral Capsule [Xalkori]
- Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic]
-
Glasgow, United Kingdom
- +7 more
Nov 1, 2021
Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States
Recruiting
- Invasive Ductal Breast Carcinoma
- +14 more
- Stereotactic body radiotherapy
- Lattice Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Apr 20, 2023
Molecular Genetic Basis of Invasive Breast Cancer Risk
Completed
- Breast Cancer
- +2 more
- Tissue specimen
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 30, 2021